Table 1 Patients characteristics
ID | stage | IPI risk | PS | extranodal involvement | immunohistochemical expression | LDH at diagnosis in U/l (Normal < 250 U/l) |
|---|---|---|---|---|---|---|
1 | II | low | 1 | oropharynx, base of the tongue | CD5, CD10, CD20, BCL2 | 122 |
2 | III | high | 1 | N | CD10, CD20, CD30, BCL2, BCL6 | 369 |
3 | II | high-intermediate | 3 | N | CD20, BCL2, BCL6, MUM1 | 718 |
4 | I | low-intermediate | 2 | stomach | CD10, CD20, BCL6 | 184 |
5 | IV | high | 1 | left thoracic wall, gluteal muscles, left kidney, spleen, liver | CD10, CD20, BCL2, BCL6, MUM1 | 312 |
6 | III | high-intermediate | 2 | bone marrow | CD20, CD79a, BCL2, BCL6, MUM1 | 180 |
7 | IV | high-intermediate | 2 | os ileum, left sacroiliac joint, lumbar vertrebal body 5, brain | CD10, CD20, CD79a, CD138, BCL2 | 196 |
8 | IV | high | 2 | skin, meninges, bone marrow | CD20, BCL2 | 164 |
9 | I | low-intermediate | 0 | both mammary glands, left adrenal gland | CD20, CD79a, BCL2, MUM1 | 150 |
10 | IV | low-intermediate | 1 | N | CD20, BCL2 | 205 |
11 | I | low-intermediate | 1 | right tonsill | CD10, CD20, BCL6 | 209 |